April 8, 2019
Jamie Blundell, President & COO was interviewed on the Midas Letter Live, discussing the many advantages CGOC offers to investors interested in the Cannabis sector:
On March 6, 2019, I had the pleasure of appearing on Midas Letter Live to discuss our value proposition for investors looking to enter the Cannabis sector. We had a great discussion on the benefits of an investment with CGOC that include:
- Having exposure to a diversified basket of public companies that are actively managed by a seasoned portfolio manager
- Exposure, through your investment in CGOC, to private companies (mostly US-based), where we see a greater opportunity for positive returns
We discussed a number of our investments including Vireo Health, and CB2 Insights (formerly Sail Cannabis), both were part of our private portfolio prior to their go public events in March 2019. We also touched on C21 Investments (CSE: CXXI), part of the public portfolio and Jushi Inc., which is part of the private portfolio of companies. Visit our website at www.cgoc.com to learn more about the us, our investee companies (both public and private), and how we can help you achieve long-term success in Cannabis.
Thanks again to the Midas Letter Live team, for having me on their show. To view the interview, follow this link.
For further information please contact Cannabis Growth Opportunity Corporation:
|Website: www.cgocorp.com||Investor Relations Email: email@example.com|